|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,230.00 GBX | -0.30% |
|
+1.82% | +10.44% |
| 08:44am | Wall Street Gets a CPI Lifeline |  |
| 07:22am | ASTRAZENECA : UBS gives a Buy rating | ZD |
Published on 03/16/2026 at 05:15 pm EDT
Health-care companies rose as a flight from high-risk market areas such as biotechnology slowed.
The iShares Nasdaq Biotechnology exchange-traded fund, a basket of biotech firms, ticked up roughly 1%, but remains in the red for the year to date.
British drugmaker AstraZeneca said it received European Union approval for its Imfinzi drug as a treatment for early-stage gastric and gastroesophageal cancers.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
03-16-26 1714ET
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
